IFIZMA Trademark

Trademark Overview

On Monday, January 7, 2019, a trademark application was filed for IFIZMA with the United States Patent and Trademark Office. The USPTO has given the IFIZMA trademark a serial number of 88252299. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, November 5, 2021. This trademark is owned by Pfizer Inc.. The IFIZMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
ifizma

General Information

Serial Number88252299
Word MarkIFIZMA
Filing DateMonday, January 7, 2019
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, November 5, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, November 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, November 5, 2021ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Friday, November 5, 2021ABANDONMENT - AFTER PUBLICATION
Thursday, November 4, 2021TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, September 14, 2021ASSIGNED TO EXAMINER
Wednesday, May 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 3, 2021EXTENSION 4 GRANTED
Monday, May 3, 2021EXTENSION 4 FILED
Monday, May 3, 2021TEAS EXTENSION RECEIVED
Tuesday, October 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 16, 2020EXTENSION 3 GRANTED
Friday, October 16, 2020EXTENSION 3 FILED
Friday, October 16, 2020TEAS EXTENSION RECEIVED
Friday, May 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 6, 2020EXTENSION 2 GRANTED
Wednesday, May 6, 2020EXTENSION 2 FILED
Wednesday, May 6, 2020TEAS EXTENSION RECEIVED
Monday, May 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 4, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, May 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 4, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 4, 2019EXTENSION 1 GRANTED
Wednesday, December 4, 2019EXTENSION 1 FILED
Wednesday, December 4, 2019TEAS EXTENSION RECEIVED
Friday, November 29, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 27, 2019ASSIGNED TO LIE
Tuesday, November 26, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 5, 2019ASSIGNED TO EXAMINER
Monday, January 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 10, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

ifizma preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological